Novartis, Voyager Therapeutics reach license option agreement for next-generation gene therapy vectors for neurological diseases
- Details
- Category: Novartis

Statement on humanitarian aid in Ukraine
- Details
- Category: Business

Boehringer Ingelheim and Lifebit announce partnership to capture transformational value of health data
- Details
- Category: Boehringer Ingelheim

Roche announces donation of essential medicines to Ukraine
- Details
- Category: Roche

Roche is working diligently to support the country and people of Ukraine with medical products in accordance with Roche's overall mission and announced today that we are donating 150,000 packages of Rocephin, a critical antibiotic used to treat the symptoms of many kinds of bacterial infections and listed on the World Health Organization's list of essential medicines.
GSK announces independent Consumer Healthcare company is to be called Haleon
- Details
- Category: GlaxoSmithKline

Haleon (pronounced "Hay-Lee-On") is inspired by the merging of the words 'Hale', which is an old English word that means 'in good health' and Leon, which is associated with the word 'strength'.
BioNTech and Medigene announce global collaboration to advance T cell receptor immunotherapies against cancer
- Details
- Category: Business

Bayer delivers on medical innovation fueling transformation of pharma business
- Details
- Category: Bayer

More Pharma News ...
- BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
- WHO grants prequalification of Actemra/RoActemra for patients with severe or critical COVID-19
- Lilly's bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19
- Sanofi completes acquisition of Amunix
- Sanofi unveils new corporate brand and logo - unites the company under one purpose and a single identity
- Valneva and Pfizer report further positive Phase 2 data for Lyme disease vaccine candidate
- Amgen and Plexium announce multi-year, drug discovery collaboration to identify novel targeted protein degradation therapies